STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
28 March 2023
KEY TAKEAWAYS
- Rapid optimization of guideline directed oral HF therapy post discharge an acute HF event under a close follow up with regular laboratory and clinical assessment is safe and reduces all cause mortality and hospital readmission.
- NT-proBNP is one of the safety parameters to not only inform the improvement of signs and symptoms of congestion but also the functioning of the heart in patients with AHF.
- STRONG-HF study now would provide us with an avenue to raise awareness on the importance of GDMT optimization post AHF discharge, through educational initiatives.
Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study of implementation of GDMT heart failure therapy that assessed the safety, tolerability of optimization of guideline directed medical therapy.
